Daniel Lysák
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 35
- Hematopoietic Stem Cell Transplantation 11
- Chronic Myeloid Leukemia Treatments 11
- Acute Myeloid Leukemia Research 9
- Genetics 32
- Chronic Lymphocytic Leukemia Research 23
- Mesenchymal stem cell research 9
- Co-authors
- Pavel Jindra (29 shared papers)Anna Dmoszyńska (1 shared paper)Mark D. Minden (1 shared paper)Wen‐Chien Chou (1 shared paper)Jiří Mayer (1 shared paper)Jacques Delaunay (1 shared paper)Albert Oriol (1 shared paper)Rena Buckstein (1 shared paper)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (4 papers)Hematological Oncology (3 papers)Annals of Hematology (3 papers)Antiviral Therapy (2 papers)
- Partner nations
- CzechiaUnited StatesUnited Kingdom
In The Last Decade
Daniel Lysák
73 papers receiving 2.0k citations
Daniel Lysák's Hit Papers
Peers
Comparison fields: 5 of 89
- Hematology 1.0k
- Genetics 639
- Pathology and Forensic Medicine 280
- Transplantation 37
- Immunology 285
Countries citing papers authored by Daniel Lysák
This map shows the geographic impact of Daniel Lysák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lysák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lysák more than expected).
Fields of papers citing papers by Daniel Lysák
This network shows the impact of papers produced by Daniel Lysák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lysák. The network helps show where Daniel Lysák may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Lysák, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia Hit paper breakdown → | 2012 | 854 |
| 2 | ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia Hit paper breakdown → | 2020 | 267 |
| 3 | 2022 | 70 | |
| 4 | 2010 | 51 | |
| 5 | 2005 | 46 | |
| 6 | 2019 | 43 | |
| 7 | 2021 | 38 | |
| 8 | Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia Hit paper breakdown → | 2025 | 36 |
| 9 | 2014 | 32 | |
| 10 | 2016 | 29 | |
| 11 | 2015 | 28 | |
| 12 | 2019 | 26 | |
| 13 | 2011 | 26 | |
| 14 | 2010 | 25 | |
| 15 | 2013 | 23 | |
| 16 | 2010 | 21 | |
| 17 | 2019 | 21 | |
| 18 | 2016 | 20 | |
| 19 | 2018 | 19 | |
| 20 | 2016 | 18 |
About Daniel Lysák
Daniel Lysák is a scholar working on Hematology, Genetics, Immunology, Pathology and Forensic Medicine and Epidemiology, having authored 83 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (14 papers), Hematopoietic Stem Cell Transplantation (11 papers), Chronic Myeloid Leukemia Treatments (11 papers), Immune Cell Function and Interaction (11 papers), Mesenchymal stem cell research (9 papers), Acute Myeloid Leukemia Research (9 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Hematology (1.0k citations), Genetics (639 citations), Pathology and Forensic Medicine (280 citations), Transplantation (37 citations) and Immunology (285 citations). Daniel Lysák has collaborated with scholars based in Czechia, United States and United Kingdom. Frequent co-authors include Pavel Jindra, Anna Dmoszyńska, Mark D. Minden, Wen‐Chien Chou, Jiří Mayer, Jacques Delaunay, Albert Oriol, Rena Buckstein, Hagop M. Kantarjian and Xavier Thomas. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, Annals of Hematology and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.